The Czech Parliament has approved a tripling of the amount of THC in industrial hemp to 3.5% from 0.3%. This is part of an effort to make the country’s cannabis industry more competitive and attractive to foreign investors.
The is hemp and cbd the same is a question that many people have been asking. Czech parliament approved tripling the amount of THC in industrial hemp from 0.3% to 1%.
If an amendment passed by the Czech Parliament is signed into law, industrial hemp may soon have a greater amount of active chemicals, and obtaining a license to produce medicinal cannabis would become much simpler. The lower chamber of the Czech Parliament, the Chamber of Deputies, has once again adopted an amendment aimed at increasing the availability of medicinal marijuana and allowing electronic prescriptions. The Senate’s proposal to keep the existing amount of THC in the definition of industrial hemp was rejected by the lower house, as was the Senate’s harsher version of certification standards.
Industrial hemp is cannabis that is used to make goods including fabric, biofuel, and animal feed. Some medicinal preparations can also be made using it.
The law will now be sent to President Milo Zeman for his signature in its original form. The amendment will take effect on January 1, 2022, if he accepts it. The adopted amendment will increase the amount of THC in industrial hemp by more than thrice to 1%.
Increasing THC concentration, according to some senators, would violate the international drug convention and have ramifications for criminal legislation relating to possession of a controlled narcotic. As a result, the Senate wanted the THC concentration ceiling for technical hemp to remain at 0.3 percent. Deputies in the lower house, on the other hand, did not concur with the Senate.
In the lower house, the Czech Pirate Party was one of the most vocal proponents of the amendment.
“This is a bundle of realistic measures, devoid of dogmatism and stereotyping, which are regrettably still key barriers for Czech policy in the area of addictive behavior,” Pirate Deputy Tomá Vymazal, who backed the plan, said on the party website.
Growers would not face prosecution as a result of good weather or other growing circumstances, he added, since the THC content in the final product cannot be anticipated in before.
“Farmers producing industrial hemp varieties from the common European catalog will not be required to verify the THC level of hemp plants – they will only be need to provide a certificate of origin,” Pirate Deputy Tomá Vymazal said on the party website.
Hemp extracts and tinctures having up to 1% THC will not be considered addictive, according to the text of the amendment submitted to the president.
“All cannabis extracts with a THC concentration of up to 1% by weight and no narcotic effects will be fully exempted from the drug misuse regime,” Vymazal said.
“This implies that, even if an ointment produced from a non-narcotic strain of cannabis includes THC and the original cannabis plant may have had more than 1% THC, it will no longer be addictive. Because the active ingredients are diluted during the ointment’s manufacturing, an extract is produced, which is not an addictive drug in the legal sense,” he said.
The amendment’s major change is that private entities will be allowed to cultivate cannabis plants for medical purposes, manufacture medicinal medicines from them, and distribute them in the same way that any other restricted drug is.
Medicinal cannabis, for example, is used to treat chronic pain that is unresponsive to conventional treatments. Multiple sclerosis, cancer, and AIDS patients are given it by specialist physicians.
The Health Ministry has said that it expects that this move would boost competition and lower the price of cannabis-based medical medicines, which are covered by public health insurance in 90% of cases. Currently, the State Institute for Drug Control (SKL) purchases the required amount of cannabis via a tender from a chosen source.
Patients will have access to a broader variety of medicinal cannabis with various dose levels as a result of additional providers, according to Vymazal.
The Senate also tried unsuccessfully to compel medical cannabis producers to obtain a certificate of good manufacturing practice for medicinal drugs granted by SKL under the Medicines Act. A statement of conformity with the criteria of good agricultural practice would suffice in the lower house version.
“Because of the more financially and administratively accessible licenses, even ordinary businesses will be able to engage in the manufacturing of cannabis for medicinal purposes,” Vymazal added.
SKL will also be able to ban websites that sell illicit or counterfeit medications as a result of the change.
Medical marijuana usage has been on the increase. According to a January study, patients were given a total of 66.8 kilos of medicinal marijuana in 2020, compared to 17 kilograms in 2019.
Since 2013, Czech legislation has permitted for the prescription of medicinal cannabis. Because there was no legal source at the time, it took two years for it to become accessible. It was once only accessible from outside the United States, and patients complained that it was excessively costly.